5-hydroxybenzimidazole: only base detected in cobamide cpds from methanol-grown Methanosarcina barkeri [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
5-hydroxybenzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole carrying a single hydroxy substituent at position 5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
ID Source | ID |
---|---|
PubMed CID | 3082533 |
CHEMBL ID | 4551859 |
CHEBI ID | 137404 |
SCHEMBL ID | 352025 |
MeSH ID | M0111002 |
Synonym |
---|
5-hydroxybenzimidazole |
5-hydroxy-1h-benzimidazole |
benzimidazol-5-ol |
CHEBI:137404 |
41292-65-3 |
1h-benzimidazol-5-ol |
3h-benzimidazol-5-ol |
149471-91-0 |
AKOS006239555 |
1h-benzimidazol-6-ol |
1h-benzo[d]imidazol-6-ol |
1h-benzo[d]imidazol-5-ol |
1h-1,3-benzodiazol-6-ol |
AKOS015856357 |
CL3532 |
STL329143 |
SCHEMBL352025 |
3h-benzoimidazol-5-ol |
PS-4150 |
KRKSOBREFNTJJY-UHFFFAOYSA-N |
1h-benzoimidazol-5-ol |
4-phosphonobutyricacid |
W-205690 |
FD13050 |
AC-28886 |
J-517611 |
1h-benzimidazol-5-ol, aldrichcpr |
DTXSID00194276 |
CS-W001209 |
mfcd02241303 |
SY037386 |
6-hydroxy-1h-benzimidazole |
FT-0764977 |
C21764 |
AMY12070 |
1h-benzimidazol-6-ol(9ci) |
EN300-108831 |
mfcd09998714 |
3h-benzoimidazol-5-ol;1h-benzo[d]imidazol-5-ol |
A849566 |
CHEMBL4551859 |
AB92482 |
Z1042386518 |
Role | Description |
---|---|
human metabolite | Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens). |
rat metabolite | Any mammalian metabolite produced during a metabolic reaction in rat (Rattus norvegicus). |
bacterial metabolite | Any prokaryotic metabolite produced during a metabolic reaction in bacteria. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
benzimidazoles | An organic heterocyclic compound containing a benzene ring fused to an imidazole ring. |
phenols | Organic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Pathway | Proteins | Compounds |
---|---|---|
5-hydroxybenzimidazolyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP | 3 | 8 |
5,6-dimethylbenzimidazole biosynthesis II (anaerobic) | 6 | 14 |
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Sulfotransferase 1A1 | Homo sapiens (human) | Km | 19.3000 | 0.1700 | 1.8343 | 6.6200 | AID1639868 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Process | via Protein(s) | Taxonomy |
---|---|---|
sulfation | Sulfotransferase 1A1 | Homo sapiens (human) |
ethanol catabolic process | Sulfotransferase 1A1 | Homo sapiens (human) |
catecholamine metabolic process | Sulfotransferase 1A1 | Homo sapiens (human) |
xenobiotic metabolic process | Sulfotransferase 1A1 | Homo sapiens (human) |
estrogen metabolic process | Sulfotransferase 1A1 | Homo sapiens (human) |
amine metabolic process | Sulfotransferase 1A1 | Homo sapiens (human) |
flavonoid metabolic process | Sulfotransferase 1A1 | Homo sapiens (human) |
3'-phosphoadenosine 5'-phosphosulfate metabolic process | Sulfotransferase 1A1 | Homo sapiens (human) |
sulfation | Sulfotransferase 1A1 | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Process | via Protein(s) | Taxonomy |
---|---|---|
aryl sulfotransferase activity | Sulfotransferase 1A1 | Homo sapiens (human) |
protein binding | Sulfotransferase 1A1 | Homo sapiens (human) |
sulfotransferase activity | Sulfotransferase 1A1 | Homo sapiens (human) |
flavonol 3-sulfotransferase activity | Sulfotransferase 1A1 | Homo sapiens (human) |
steroid sulfotransferase activity | Sulfotransferase 1A1 | Homo sapiens (human) |
3'-phosphoadenosine 5'-phosphosulfate binding | Sulfotransferase 1A1 | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Process | via Protein(s) | Taxonomy |
---|---|---|
cytosol | Sulfotransferase 1A1 | Homo sapiens (human) |
cytoplasm | Sulfotransferase 1A1 | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.47) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |